Dhifaf Sarhan - Related publications

Oncology and Pathology Karolinska Instituet 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
21 most relevant papers in past 60 days:
Year Citation  Score
2022 Wang Z, Liu Y, Peng L, Till B, Liao Y, Yuan S, Yan X, Chen L, Fu Q, Qin Z. Role of fibrosarcoma-induced CD11b myeloid cells and tumor necrosis factor-α in B cell responses. Oncogene. PMID 35034094 DOI: 10.1038/s41388-022-02187-z   
2022 Chen WJ, Cao H, Cao JW, Zuo L, Qu FJ, Xu D, Zhang H, Gong HY, Chen JX, Ye JQ, Gan SS, Zhou W, Zhu DW, Pan XW, Cui XG. Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study. Cell Death & Disease. 13: 50. PMID 35017463 DOI: 10.1038/s41419-022-04501-9   
2022 Chen BJ, Zhao JW, Zhang DH, Zheng AH, Wu GQ. Immunotherapy of Cancer by Targeting Regulatory T cells. International Immunopharmacology. 104: 108469. PMID 35008005 DOI: 10.1016/j.intimp.2021.108469   
2022 Liu JQ, Geng XR, Hu TY, Mo LH, Luo XQ, Qiu SY, Liu DB, Liu ZG, Shao JB, Liu ZQ, Yang PC. Glutaminolysis is required in maintaining immune regulatory functions in B cells. Mucosal Immunology. PMID 35013572 DOI: 10.1038/s41385-021-00481-9   
2022 Yang Q, Hao J, Chi M, Wang Y, Li J, Huang J, Zhang J, Zhang M, Lu J, Zhou S, Yuan T, Shen Z, Zheng S, Guo C. D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35007759 DOI: 10.1016/j.ymthe.2022.01.007   
2022 Murray MP, Crosby CM, Marcovecchio P, Hartmann N, Chandra S, Zhao M, Khurana A, Zahner SP, Clausen BE, Coleman FT, Mizgerd JP, Mikulski Z, Kronenberg M. Stimulation of a subset of natural killer T cells by CD103 DC is required for GM-CSF and protection from pneumococcal infection. Cell Reports. 38: 110209. PMID 35021099 DOI: 10.1016/j.celrep.2021.110209   
2022 Lu Y, Xue G, Zheng N, Han K, Yang W, Wang RS, Wu L, Miller LD, Pardee T, Triozzi PL, Lo HW, Watabe K, Wong STC, Pasche BC, Zhang W, et al. hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy. Briefings in Bioinformatics. PMID 35037026 DOI: 10.1093/bib/bbab575   
2022 Fang F, Xie S, Chen M, Li Y, Yue J, Ma J, Shu X, He Y, Xiao W, Tian Z. Advances in NK cell production. Cellular & Molecular Immunology. PMID 34983953 DOI: 10.1038/s41423-021-00808-3   
2022 Tang J, Zhu Q, Li Z, Yang J, Lai Y. Natural killer cell-targeted immunotherapy for cancer. Current Stem Cell Research & Therapy. PMID 34994316 DOI: 10.2174/1574888X17666220107101722   
2022 Shakiba M, Zumbo P, Espinosa-Carrasco G, Menocal L, Dündar F, Carson SE, Bruno EM, Sanchez-Rivera FJ, Lowe SW, Camara S, Koche RP, Reuter VP, Socci ND, Whitlock B, Tamzalit F, et al. TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion. The Journal of Experimental Medicine. 219. PMID 34935874 DOI: 10.1084/jem.20201966   
2022 Wang X, Urak R, Walter M, Guan M, Han T, Vyas V, Chien SH, Gittins B, Clark MC, Mokhtari S, Cardoso A, Diamond DJ, Zaia J, Forman SJ, Nakamura R. Large-scale manufacturing and characterization of CMV-CD19CAR T cells. Journal For Immunotherapy of Cancer. 10. PMID 35027426 DOI: 10.1136/jitc-2021-003461   
2022 Huan T, Chen D, Liu G, Zhang H, Wang X, Wu Z, Wu Y, Xu Q, Yu F. Activation-induced cell death in CAR-T cell therapy. Human Cell. PMID 35032297 DOI: 10.1007/s13577-022-00670-z   
2022 Hinterleitner M, Hinterleitner C, Malenke E, Federmann B, Holzer U, Müller M, Bethge WA, Wirths S. Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation. Journal of Clinical Medicine. 11. PMID 35012014 DOI: 10.3390/jcm11010270   
2022 Sun S, Shi R, Xu L, Sun F. Identification of heterogeneity and prognostic key genes associated with uveal melanoma using single-cell RNA-sequencing technology. Melanoma Research. 32: 18-26. PMID 34879031 DOI: 10.1097/CMR.0000000000000783   
2022 Zhu L, Feng R, Chen G, Wang C, Liu Z, Zhang Z, Chen H. Glycopolymer Engineering of the Cell Surface Changes the Single Cell Migratory Direction and Inhibits the Collective Migration of Cancer Cells. Acs Applied Materials & Interfaces. PMID 35041374 DOI: 10.1021/acsami.1c20297   
2022 Qiu Y, Meng M, Cao C, Zhang J, Cheng X, Huang Y, Cao H, Li Y, Tian D, Huang Y, Peng L, Hu K, Zhang Y, Liao J, He J, et al. RNA-binding protein MEX3A controls G1/S transition via regulating the RB/E2F pathway in clear cell renal cell carcinoma. Molecular Therapy. Nucleic Acids. 27: 241-255. PMID 34976441 DOI: 10.1016/j.omtn.2021.11.026   
2022 Chaurio RA, Anadon CM, Lee Costich T, Payne KK, Biswas S, Harro CM, Moran C, Ortiz AC, Cortina C, Rigolizzo KE, Sprenger KB, Mine JA, Innamarato P, Mandal G, Powers JJ, et al. TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures. Immunity. 55: 115-128.e9. PMID 35021053 DOI: 10.1016/j.immuni.2021.12.007   
2022 Bao L, Bo XC, Cao HW, Qian C, Wang Z, Li B. Engineered T cells and their therapeutic applications in autoimmune diseases. Zoological Research. 43: 150-165. PMID 35008131 DOI: 10.24272/j.issn.2095-8137.2021.363   
2022 Ju SA, Park SM, Joe Y, Chung HT, An WG, Kim BS. Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11cCD8 T cells in renal cell carcinoma. Oncology Letters. 23: 43. PMID 34976155 DOI: 10.3892/ol.2021.13161   
2022 Lee GJ, Jun Y, Jeon YK, Lee D, Lee S, Kim J. Mice transgenic for human fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells. Oncoimmunology. 11: 2015170. PMID 35003894 DOI: 10.1080/2162402X.2021.2015170   
2022 Chang YT, Ignatova D, Hoetzenecker W, Pascolo S, Fassnacht C, Guenova E. Increased Chlormethine-Induced DNA Double-Stranded Breaks in Malignant T Cells from Mycosis Fungoides Skin Lesions. Jid Innovations. 2: 100069. PMID 34977846 DOI: 10.1016/j.xjidi.2021.100069